Skip to main content
Equibles

Steven Gavel

Cabaletta Bio, Inc. (CABA)

Equibles does not estimate personal net worth.

Get an email with a short summary when Cabaletta Bio, Inc. publishes a filing, an earnings call transcript or a press release.

Get CABA alerts

About Steven Gavel

Steven Gavel has spoken on 4 investor events across 1 company, most recently for Cabaletta Bio, Inc. on November 10, 2026. Cabaletta Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cabaletta Bio, Inc. includes Steven Nichtberger (CEO and Board Member), Anup Marda (CFO), Michael Gerard (General Counsel) and 4 others.

Steven Gavel on recent calls

“You know, when I started a year or so ago, our tox profile always seemed to be a key differentiator amongst the class.”
Other, Guggenheim’s 3rd Annual Healthcare Innovation Conference ·
“So there's a very clear two-year threshold requirement from the private insurers. We'll be well beyond that once we launch. The one thing, though, I do want to say, we haven't really got into this, but it's very clear in this space.”
Board Member, H.C. Wainwright 28th Annual Global Investment Conference ·
“So there's a very clear two-year threshold requirement from the private insurers. We'll be well beyond that once we launch. The one thing, though, I do want to say, we haven't really got into this, but it's very clear in this space.”
Other, Morgan Stanley 24th Annual Global Healthcare Conference ·
“So, you know, Stephen talked about the Nature Biotech article. You know, we're kind of clearing that first toxicity question around the program. Best in class, it appears to now.”
Board Member, Goldman Sachs 47th Annual Global Healthcare Conference ·

Affiliation history

Company network

Leadership on record at Cabaletta Bio, Inc.

Recent activity